Month: July 2024

Company to host conference call and webcast at 4:30 pm ET / 1:30 pm PT BURLINGAME, Calif., July 31, 2024 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that the company will host a conference call and webcast on August 6, 2024 at 4:30 pm ET (1:30 pm PT) to provide a business update and report second quarter 2024 financial results. The conference call can be accessed by dialing 1-800-717-1738 (toll-free domestic) or 1-646-307-1865 (international) or by clicking on this link for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the Corvus website. A replay of the webcast will be available on Corvus’ website for 90 days. About Corvus PharmaceuticalsCorvus Pharmaceuticals is a clinical-stage biopharmaceutical...

Company to host conference call after the market closes at 4:30 p.m. ET on Wednesday, August 14th GOLDEN, Colo., July 31, 2024 (GLOBE NEWSWIRE) — SHF Holdings, Inc., d/b/a/ Safe Harbor Financial (“Safe Harbor” or the “Company”) (NASDAQ: SHFS), a leader in facilitating financial services and credit facilities to the regulated cannabis industry, today announced that it will report financial results for the second quarter of 2024 ended June 30, 2024 on Wednesday, August 14, 2024 after the close of the market. Chief Executive Officer, Sundie Seefried, and Chief Financial Officer, Jim Dennedy, will host a conference call and webcast at 4:30 pm ET / 1:30 pm PT on August 14, 2024 to discuss the Company’s financial results and provide investors with key business highlights. For those interested in listening in to the conference call,...

Conference Call and Webcast Scheduled for August 7, 2024 at 2:00 p.m. PT/5:00 p.m. ETSOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will report second quarter 2024 financial results and provide a business update on August 7, 2024, after the close of the market. The announcement will be followed by a live audio webcast and conference call at 2:00 p.m. PT/5:00 p.m. ET. Listen-Only WebcastThe listen-only webcast will be made available on the Company’s website at www.allogene.com under the Investors tab in the News and Events section. A replay will be available on the Company’s website for...

VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) — Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Company” or “Treatment”), a healthcare tech company transforming patient care with AI-driven clinical insights is excited to announce a new solution, AI Pharmacy Assistant designed to support pharmacists. Pharmacists are playing an increasing role in the provision of clinical decision support services, given the increasing number of people without a GP and/or the time taken to book appointments. As one example, the Ontario government recently announced pharmacies provided over 1 million assessments for common ailments since last year Ontario Exploring More Ways to Expand Role of Pharmacists | Ontario Newsroom. This is representative of similar trends being seen across Canada, UK and emerging legislation...

BEIJING, July 31, 2024 (GLOBE NEWSWIRE) — Global Mofy Metaverse Limited (the “Company” or “Global Mofy”) (Nasdaq: GMM), a generative AI-driven technology solutions provider engaged in virtual content production and the development of 3D digital assets for use in the broader digital content industry, today announced that CEO Mr. Haogang Yang, invited by NVIDIA China, concluded his participation at SIGGRAPH 2024 in Denver, Colorado. This prominent event, supported by NVIDIA, offered Mr. Yang the invaluable opportunity to engage with key industry leaders, delve into the latest advancements in generative AI and computer graphics, and explore the future direction of the digital content industry. During SIGGRAPH 2024, Mr. Yang attended keynote presentations by NVIDIA CEO Jensen Huang and Meta CEO Mark Zuckerberg...